Guidelines

• NCCN Guidelines Version 1.2022

Evidence Blocks

• NCCN Guidelines with Evidence Blocks Version 1.2022

Frameworks

• Enhanced Resources (English) Version 3.2020

• Basic Resources (English) Version 3.2020

• Core Resources (English) Version 3.2020

Guidelines for Patients

• Non-Small Cell Lung Cancer - Early and Locally Advanced-English Version 2021

• Non-Small Cell Lung Cancer - Metastatic-English Version 2021

• Non-Small Cell Lung Cancer - Early and Locally Advanced-Russian Version 2019

• Non-Small Cell Lung Cancer - Metastatic-Russian Version 2019

Educational Events and Programs

Calendar of Events

Continuing Education

• NCCN Guidelines® Insights - Non–Small Cell Lung Cancer, Version 2.2021

• Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer

• Accurate Diagnosis and Personalized Treatment of NSCLC for the Interdisciplinary Team

• Keeping up with the Molecular Targets in the Treatment of Advanced Non-Small Cell Lung Cancer

• Multidisciplinary Treatment of Early-Stage Non-Small Cell Lung Cancer

• Challenging Case Review: Non-Small Cell Lung Cancer

• Non-Small Cell Lung Cancer: Biomarker Testing Recommendations

• New Targeted Therapies and Immunotherapies for Metastatic Non-Small Cell Lung Cancer

• TARGET FOR NSCLC: The Advancing Research into Genomic Pathways and use of EGFR Therapies

• Clinical Scenario #1: Applying Biomarkers in Metastatic Non-Small Cell Lung Cancer

International

Disclosures

• Disclosure Policy

• Panel Member Disclosures

• Panel Member Disclosures by Meeting Date

• End User License Agreement